Silverman P M, O'Malley J, Tefft M C, Cooper C, Zeman R K
Department of Radiology, Georgetown University Medical Center, Washington, DC 20007.
AJR Am J Roentgenol. 1995 Mar;164(3):619-23. doi: 10.2214/ajr.164.3.7863882.
The purpose of this study was to compare two time delays between injection of contrast material and helical CT scanning to determine relative conspicuity of hepatic metastases.
Twenty-five patients with hepatic metastases were examined with helical CT. The first imaging phase was initiated at 50 sec and the second 75 sec after the start of contrast material injection (3 ml/sec, 150 ml). Differences in lesion and liver attenuation were measured quantitatively. Four radiologists used a 5-point scale to assess lesion conspicuity subjectively.
Mean differences in enhancement between liver and lesion were 41 H during the first phase and 59 H for the second phase (p = .0001). Radiologists' conspicuity score averaged 2.4 for lesions in the first phase versus 3.3 for lesions in the second phase (p = .0001). In 56 (88%) of 64 lesions, objective measurements showed greater enhancement of lesions during the later phase. Radiologists found 60 (94%) of 64 lesions to be more conspicuous on these later images.
Our results show that conspicuity of hepatic metastases on helical CT scans is better with a 75-sec scan delay between contrast administration and scanning than with a 50-sec scan delay. The longer delay time should be used when scanning is used to detect metastases.
本研究旨在比较注射造影剂与螺旋CT扫描之间的两个时间延迟,以确定肝转移瘤的相对显影度。
对25例肝转移瘤患者进行螺旋CT检查。在开始注射造影剂(3ml/秒,150ml)后50秒启动第一期成像,75秒启动第二期成像。定量测量病变和肝脏的衰减差异。四位放射科医生使用5分制主观评估病变的显影度。
第一期肝脏与病变之间的增强平均差异为41H,第二期为59H(p = 0.0001)。放射科医生对第一期病变的显影度评分平均为2.4,而第二期病变为3.3(p = 0.0001)。在64个病变中的56个(88%)中,客观测量显示后期病变增强更大。放射科医生发现64个病变中的60个(94%)在这些后期图像上更明显。
我们的结果表明,在螺旋CT扫描中,造影剂注射与扫描之间延迟75秒时肝转移瘤的显影度比延迟50秒时更好。当扫描用于检测转移瘤时,应采用更长的延迟时间。